Neurogene Inc (NGNE)
Healthcare
Biotechnology
—
32.90 $
-0.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Neurogene Inc (NGNE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 44.3% of the shares are freely tradable; institutional investors hold 110.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
110.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
8.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
44.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
17.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
20Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Samsara BioCapital, LLC | 8.61 | 1,717,127 | +0.0 | 03/31/2026 |
| Redmile Group, LLC | 7.32 | 1,459,599 | +0.0 | 03/31/2026 |
| Casdin Capital, LLC | 7.12 | 1,420,361 | +9.6 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 6.83 | 1,362,456 | +0.0 | 03/31/2026 |
| EcoR1 Capital, LLC | 6.37 | 1,271,342 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.04 | 1,005,070 | +6.3 | 03/31/2026 |
| Baker Bros Advisors LP | 4.97 | 991,691 | +0.0 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 3.92 | 782,787 | -0.3 | 03/31/2026 |
| Balyasny Asset Management LLC | 3.60 | 718,389 | +18.0 | 03/31/2026 |
| The Toronto-Dominion Bank | 3.42 | 681,337 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.